- Home
- VTAK vs JXG Comparison
VTAK vs JXG Comparison
Compare VTAK & JXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTAK
- JXG
- Stock Information
- Founded
- VTAK 2002
- JXG N/A
- Country
- VTAK United States
- JXG China
- Employees
- VTAK N/A
- JXG N/A
- Industry
- VTAK Medical/Dental Instruments
- JXG
- Sector
- VTAK Health Care
- JXG
- Exchange
- VTAK Nasdaq
- JXG Nasdaq
- Market Cap
- VTAK 3.9M
- JXG 4.6M
- IPO Year
- VTAK 2018
- JXG N/A
- Fundamental
- Price
- VTAK $3.04
- JXG $1.02
- Analyst Decision
- VTAK
- JXG
- Analyst Count
- VTAK 0
- JXG 0
- Target Price
- VTAK N/A
- JXG N/A
- AVG Volume (30 Days)
- VTAK 3.1M
- JXG 160.8K
- Earning Date
- VTAK 08-11-2025
- JXG 05-15-2025
- Dividend Yield
- VTAK N/A
- JXG N/A
- EPS Growth
- VTAK N/A
- JXG N/A
- EPS
- VTAK N/A
- JXG 0.86
- Revenue
- VTAK $600,000.00
- JXG $49,840,288.00
- Revenue This Year
- VTAK $822.86
- JXG N/A
- Revenue Next Year
- VTAK $168.42
- JXG N/A
- P/E Ratio
- VTAK N/A
- JXG $1.23
- Revenue Growth
- VTAK 37.62
- JXG 56.53
- 52 Week Low
- VTAK $2.49
- JXG $0.55
- 52 Week High
- VTAK $43.70
- JXG $8.40
- Technical
- Relative Strength Index (RSI)
- VTAK 44.02
- JXG 42.32
- Support Level
- VTAK $2.70
- JXG $0.97
- Resistance Level
- VTAK $4.31
- JXG $1.10
- Average True Range (ATR)
- VTAK 0.37
- JXG 0.10
- MACD
- VTAK 0.03
- JXG 0.03
- Stochastic Oscillator
- VTAK 30.22
- JXG 72.41
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.
About JXG JX Luxventure Limited Common Stock
JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products.